Table of contents

• Acknowledgements and feedback
• Abbreviations and Notes    
• Section 1. Purpose of these Guidelines    
  • 1.1 Purpose    
  • 1.2 What substances are included within the scope of the Early Warning System?    
  • 1.3 Early detection, reporting, assessment, and response    
• Section 2. Responding to new psychoactive substances in Europe    
  • 2.1 A history of the EU response    
  • 2.2 Global markets, glocal threats: the case for strengthened early warning, preparedness, and response    
• Section 3. Scope of the legislation and steps    
  • 3.1 Scope of the legislation and definition of a new psychoactive substance    
  • 3.2 The three steps: early warning, risk assessment, and control measures    
• Section 4. EU Early Warning System    
  • 4.1 Legal basis and scope    
  • 4.2 Information collection and reporting by the Member States    
  • 4.3 Information sources at Member State level    
  • 4.4 Health threats related to existing psychoactive substances    
  • 4.5 Communication within the Network    
  • 4.6 Reitox NFP Early Warning System Correspondents    
  • 4.7 Data protection    
  • 4.8 Classified information    
  • 4.9 Retraction of information    
  • 4.10 EMCDDA Systems    
  • 4.11 Outputs of the Early Warning System    
• Section 5. Initial report    
  • 5.1 Background    
  • 5.2 Assessment of existing information    
  • 5.3 Collection of additional information    
  • 5.4 Production and structure of the initial report    
  • 5.5 Submission of the initial report    
• References